BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11137984)

  • 1. The power of point mutations.
    Maquat LE
    Nat Genet; 2001 Jan; 27(1):5-6. PubMed ID: 11137984
    [No Abstract]   [Full Text] [Related]  

  • 2. Listening to silence and understanding nonsense: exonic mutations that affect splicing.
    Cartegni L; Chew SL; Krainer AR
    Nat Rev Genet; 2002 Apr; 3(4):285-98. PubMed ID: 11967553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.
    Liu HX; Cartegni L; Zhang MQ; Krainer AR
    Nat Genet; 2001 Jan; 27(1):55-8. PubMed ID: 11137998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
    Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
    Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
    Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre-mRNA splicing: a source of a diversified gene expression network].
    Mayeda A; Suzuki H
    Tanpakushitsu Kakusan Koso; 2003 Mar; 48(4 Suppl):404-13. PubMed ID: 12696148
    [No Abstract]   [Full Text] [Related]  

  • 7. Making structural sense of nonsense-mediated decay.
    Lykke-Andersen J
    Nat Struct Mol Biol; 2004 Apr; 11(4):305-6. PubMed ID: 15048104
    [No Abstract]   [Full Text] [Related]  

  • 8. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
    Kouidou S; Malousi A; Maglaveras N
    Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel LDL receptor mutations in familial hypercholesterolemia: C122Y and E296X.
    Genschel J; Thomas HP; Kassner U; Lochs H; Steinhagen-Thiessen E; Schmidt HH
    Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295843
    [No Abstract]   [Full Text] [Related]  

  • 10. ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs.
    Shotelersuk V; Desudchit T; Tongkobpetch S
    Int J Mol Med; 2004 Oct; 14(4):683-9. PubMed ID: 15375602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively spliced TCR mRNA induced by disruption of reading frame.
    Wang J; Hamilton JI; Carter MS; Li S; Wilkinson MF
    Science; 2002 Jul; 297(5578):108-10. PubMed ID: 12098701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells.
    Lejeune F; Maquat LE
    Curr Opin Cell Biol; 2005 Jun; 17(3):309-15. PubMed ID: 15901502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in the SDHD gene responsible for familial paraganglioma. Medical and psychological implications.
    Prontera P; Ferrando B; Giuliani V; Falcinelli F; Mencarelli A; Rogaia D; Pasini B; Donti E
    Genet Couns; 2008; 19(4):413-8. PubMed ID: 19239085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deeper understanding of unclassified intronic variants and ESEs.
    Rogan PK
    Hum Mutat; 2010 Apr; 31(4):V. PubMed ID: 20358580
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex.
    Kim VN; Kataoka N; Dreyfuss G
    Science; 2001 Sep; 293(5536):1832-6. PubMed ID: 11546873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms in aberrant splicing in neurological disorders].
    Imaizumi K
    Tanpakushitsu Kakusan Koso; 2005 Apr; 50(4):330-42. PubMed ID: 15828279
    [No Abstract]   [Full Text] [Related]  

  • 18. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
    Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G
    Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.